Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.

Current opinion in oncology - 1 Sept 2011

Long Kara C, Kauff Noah D

Abstract excerpt

PURPOSE OF REVIEW: This review will focus on the implications of BRCA status in the patient with high-grade serous ovarian cancer, the differences between BRCA1 and BRCA2 mutations, and the most effective risk-reducing strategies. RECENT FINDINGS: Women with BRCA-associated epithelial ovarian can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, BRCA1
Share to Genes, BRCA2
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Phenotype

Share to Prognosis

Share to Risk Reduction Behavior

Source

Identifiers

PMID: 21734577
DOI: 10.1097/CCO.0b013e3283499da9

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21734577-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.PMID 21734577Read ↗

BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar populationSemantic proximity Read ↗

Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.Semantic proximity Read ↗

The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.Semantic proximity Read ↗

BRCA mutation in ovarian cancer: testing, implications and treatment considerationsSemantic proximity Read ↗

Hereditary Ovarian Cancer and Risk Reduction.Semantic proximity Read ↗

BRCA-associated ovarian cancer: from molecular genetics to risk management.Semantic proximity Read ↗

Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers.Semantic proximity Read ↗

BRCA mutations: Implications of genetic testing in ovarian cancer.Semantic proximity Read ↗

Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.Semantic proximity Read ↗

Epithelial Ovarian Cancer: Providing Evidence of Predisposition GenesSemantic proximity Read ↗

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapySemantic proximity Read ↗

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.